We are pleased to share that Prof. Magdalena Król, Head of the Department, has been awarded with the MACOV Transition Grant funded by the European Innovation Council (EIC)! The project MACOV aims to develop an innovative, allogeneic, off-the-shelf macrophage-based therapy for platinum-resistant ovarian cancer. This is a ground-breaking, first in class therapy that shows very high efficacy in multiple solid tumors of unmet medical need.
Institute of Biology | Warsaw University of Life Sciences
